  | Kahvecioglu, Z. C., Vandecasteele, S., Bougard, M., Peeters, S., Daubry, A., Journe, F., Laurent, S., Saussez, S., & Burtea, C. (24 November 2023). Innovative drug delivery system using EGFR-targeted engineered peptides in anaplastic thyroid cancer treatment [Poster presentation]. PhD Day SFMBBM 2023, Liège, Belgium.  Peer reviewed |
 | Kahvecioglu, Z. C.* , Vandecasteele, S., Bougard, M., Rogien, C., Daubry, A., Journe, F., Laurent, S., Saussez, S., & Burtea, C. (27 October 2023). Novel therapeutic approaches for EGFR-mediated drug delivery using engineered peptides in anaplastic thyroid cancer [Poster presentation]. Annual BACR Meeting 2023 Friday October 27th, CIRCADIAN CYCLE, CHRONOBIOLOGY AND CANCER, brussels, Belgium. Peer reviewed |
 | Kahvecioglu, Z. C., Samuel Vandecasteele, Marine Bougard, Charlotte Rogien, Journe, F., Laurent, S., Saussez, S., & Burtea, C. (02 July 2023). Development of a novel EGFR-targeted peptide for targeted delivery of drugs in anaplastic thyroid cancer [Poster presentation]. PBA 2023 33rd International Symposium on Pharmaceutical and Biomedical Analysis, ankara, Turkey. Peer reviewed |
 | Balas, M., Predoi, D., Burtea, C., & Dinischiotu, A. (07 February 2023). New Insights into the Biological Response Triggered by Dextran-Coated Maghemite Nanoparticles in Pancreatic Cancer Cells and Their Potential for Theranostic Applications. International Journal of Molecular Sciences, 24 (4), 3307. doi:10.3390/ijms24043307 Peer Reviewed verified by ORBi |
 | Kahvecioglu, Z. C., Toulehohoun, A., Feudjio Tagny, D., Rogien, C., Vandecasteele, S., Journe, F., Laurent, S., Saussez, S., & Burtea, C. (02 February 2023). A study of combined targeted therapy and delivery, inducing an inhibition of PI3K/AKT/mTOR pathway in anaplastic thyroid cancer cells [Paper presentation]. 2023 Télévie Seminar, bruxelles, Belgium. |
M. Limpens, Derenne, A., Burtea, C., Laurent, S., A. Legrand, S. Wilton, A. Belayew, F. Coppée, A-E. Declèves, & A. Tassin. (2023). Selection of peptides for a muscle-targeted delivery of ASO directed against DUX4 mRNAs through complementary approaches in silico, in vitro and in vivo. Poster session presented at FSH Society, Milan, Italy. Peer reviewed |
Limpens, M., Derenne, A., Burtea, C., Laurent, S., Legrand, A., Wilton, S., Belayew, A., Coppée, F., Decleves, A.-E., & Tassin, A. (2023). Selection of peptides for a muscle-targeted delivery of ASO directed against DUX4 mRNAs through complementary approaches in silico, in vitro and in vivo. Paper presented at Physphar Spring meeting (2023), Brussels, Belgium. Editorial reviewed |
 | Tchéoubi, S. E. R., Akpovi, C. D., Coppée, F., Decleves, A.-E., Laurent, S., Agbangla, C., & Burtea, C. (November 2022). Molecular and cellular biology of PCSK9: impact on glucose homeostasis. Journal of Drug Targeting, 30 (9), 948 - 960. doi:10.1080/1061186X.2022.2092622 Peer Reviewed verified by ORBi |
Tchéoubi, E. S. R., Akpovi, C. D., Coppée, F., Tassin, A., Decleves, A.-E., Fiogbé, S. E., Sègbo, G. J., Laurent, S., & Burtea, C. (11 September 2022). PCSK9 variants affect differently the risk of type 2 diabetes mellitus development. Potential impact on the therapy with PCSK9 inhibitors. Poster session presented at 12th International Symposium on Drug Analysis & 32nd International Symposium on Pharmaceutical and Biomedical Analysis. Peer reviewed |
| Kahvecioglu, Z. C., Toulehohoun, A., Feudjio Tagny, D., Rogien, C., Vandecasteele, S., Rogien, C., Journe, F., Laurent, S., Saussez, S., & Burtea, C. (11 September 2022). Novel therapeutic strategy targeting the EGFR and inhibiting PI3K/AKT/mTOR pathway in anaplastic thyroid carcinoma [Poster presentation]. 12th International Symposium on Drug Analysis & 32nd International Symposium on Pharmaceutical and Biomedical Analysis, Mons, Belgium. Peer reviewed |
 | LIMPENS, M., Derenne, A., Burtea, C., Legrand, A., Decleves, A.-E., Coppée, F., & Tassin, A. (17 June 2022). Towards a muscle-targeted delivery of antisense agents against DUX4. Poster session presented at The 29th FSHD Society's annual International Research Congress 2022. Editorial reviewed |
  | Boutry, S., Laurent, S., & Burtea, C. (2022). Editorial for "New Cluster Analysis Method for Quantitative DCE-MRI Assessing Tumor Heterogeneity Induced by E7130 Treatment to a Breast Cancer Mouse Model". Journal of Magnetic Resonance Imaging. doi:10.1002/jmri.28225 Editorial reviewed |
Kahvecioglu, Z. C., Toulehohoun, A., Feudjio Tagny, D., Journe, F., Laurent, S., Saussez, S., & Burtea, C. (08 April 2022). PI3K/AKT/mTOR pathway inhibition and targeted drug delivery combined in a novel therapeutic strategy addressed to anaplastic thyroid carcinoma [Poster presentation]. Séminaire Télévie. Peer reviewed |
 | Kahvecioglu, Z. C.* , Bruynbroeck, M., Gheysen, L., Journé, F., Laurent, S., Saussez, S., & Burtea, C.*. (22 September 2021). Delivery of a drug molecule to thyroid cancer cells via EGFR targeting. Poster session presented at 'Adaptation of the tumour and its ecosystem to radiotherapies' workshop ,September 22nd-25th, 2021, Manoir de Kerdréan, Le Bono, France. Peer reviewed |
 | TCHEOUBI, S. E. R.* , AKPOVI, C. D., Coppée, F., Decleves, A.-E., FIOGBE, S. E., Sègbo, G. J., AGBANGLA, C., Laurent, S., & Burtea, C. (06 September 2021). PCSK9 intronic variant rs142149050 is associated with low level of LDL-cholesterol and lower cardiovascular risk in type 2 diabetes. Paper presented at - 4ème Congrès international de la Société Africaine de Physiologie et Physiopathologie (SA2P), Cotonou, Benin. Peer reviewed |
 | Burtea, C., Laurent, S., & ANDRE, S. (17 June 2021). PEPTIDES BINDING TO LDL-RECEPTOR AS CARRIERS FOR CROSSING THE BLOOD BRAIN BARRIER. |
 | Kahvecioglu, Z. C., Gheysen, L., Journe, F., Laurent, S., Saussez, S., & Burtea, C. (21 May 2021). Toward the development of peptide inhibitors targeted to PI3K/AKT signalling pathway for the therapy of anaplastic thyroid carcinoma [Poster presentation]. 27th Porto Cancer meeting Stemness & Metastasis: Advances in Research and Clinical Translation, Porto, Portugal. |
 | Crombez, D., Delcambre, S., Nonclercq, D., Vander Elst, L., Laurent, S., Cnop, M., Muller, R., & Burtea, C. (15 August 2020). Modulation of Adiponectin Receptors AdipoR1 and AdipoR2 by Phage Display-Derived Peptides in in vitro and in vivo Models. Journal of Drug Targeting, 28 (7-8), 831-851. doi:10.1080/1061186X.2019.1710840 Peer Reviewed verified by ORBi |
Tchéoubi, E. R. S., AKPOVI, C. D., Coppée, F., Decleves, A.-E., Sègbo, G. J., AGBANGLA, C., Laurent, S., & Burtea, C. (24 July 2020). A novel cholesterol-lowering PCSK9 variant is associated with low blood glucose level and lower cardiovascular risk in type 2 diabetes. Paper presented at 4th Global Summit on Diabetes and Endocrinology, Scientific Federation-Diabetes, Manchester, Unknown/unspecified. |
 | Popescu Din, I. M., Balas, M., Hermenean, A., Vander Elst, L., Laurent, S., Burtea, C., Cinteza, L. O., & Dinischiotu, A. (2020). Novel Polymeric Micelles-Coated Magnetic Nanoparticles for In Vivo Bioimaging of Liver: Toxicological Profile and Contrast Enhancement. Materials. Peer reviewed |
 | Andre, S., Larbanoix, L., Verteneuil, S., Stanicki, D., Nonclercq, D., Vander Elst, L., Laurent, S., Muller, R., & Burtea, C. (05 June 2020). Development of an LDL receptor-targeted peptide susceptible to facilitate the brain access of diagnostic or therapeutic agents. Biology, 9, 161, 1-26. doi:10.3390/biology9070161 Peer reviewed |
 | Canei, J., Burtea, C., & Nonclercq, D. (17 April 2020). Comparative study of the visual system of two psammophilic lizards (Scincus scincus & Eumeces schneideri). Vision Research, 171, 17-30. Peer Reviewed verified by ORBi |
 | Fanfone, D., Stanicki, D., Nonclercq, D., Port, M., Vander Elst, L., Laurent, S., Muller, R., Saussez, S., & Burtea, C. (14 March 2020). Molecular Imaging of Galectin-1 Expression as a Biomarker of Papillary Thyroid Cancer by Using Peptide-Functionalized Imaging Probes. Biology, 9 (53), 1-25. doi:10.3390/biology9030053 Peer reviewed |
 | Tchéoubi, E. R. S., AKPOVI, C. D., & Burtea, C. (27 January 2020). Effets des mutations de la PCSK9 sur le profil lipidique et l'adiponectine chez les patients diabétiques au Bénin. Poster session presented at Evénement de maillage UMONS-CHU Ambrise Paré (UMHAP), Mons, Mons, Belgium. |
 | Burtea, C., & Laurent, S. (27 January 2020). Nouvelle approche de ciblage moléculaire dans le domaine de la santé. Poster session presented at Evénement de maillage UMONS-CHU Ambrise Paré (UMHAP), Mons, Mons, Belgium. |
Burtea, C., Saussez, S., Port, M., Burtea, C. (Ed.), Saussez, S. (Ed.), & Port, M. (Ed.). (2020). Molecular Targets and Targeting in Biomedical Sciences. MDPI Basel. |
 | Burtea, C., Andre, S., & Laurent, S. (10 December 2019). Peptides binding to LDL receptor as carriers for crossing the blood-brain barrier. |
 | Andre, S., Atakana Lukulu, J. M., Lecomte, M., Muller, R., Vander Elst, L., Laurent, S., & Burtea, C. (28 October 2019). A promising phospholipase A2 targeted peptide slowing amyloid beta pathology in an Alzheimer's disease mouse model. Poster session presented at the 2nd International Conference on Neurovascular and Neurodegenerative Diseases, Paris, France. |
 | TCHEOUBI, S. E. R., AKPOVI, C. D., Coppée, F., Decleves, A.-E., Laurent, S., AGBANGLA, C., & Burtea, C. (16 September 2019). PCSK9 synonymous variant gln342=, insulin and adiponectin levels in type 2 diabetes mellitus patients. Paper presented at VIIème Colloques des sciences, cultures et technologies, Campus universitaire d'Abomey-Calavi, Benin. |
TCHEOUBI, S. E. R., AKPOVI, C. D., FIOGBE, S. E., KOUGNIMON, F. E., SEGBO, J. A., SAGBO, G. G., Burtea, C., & AGBANGLA, C. (21 June 2019). Gestational diabetes mellitus is associated with a decrease in calcium and glucose levels in newborn. Paper presented at 2ème Journées Africaines d'Endocrinologie clinique, Abidjan, Côte d’Ivoire. |
TCHEOUBI, S. E. R., AKPOVI, C. D., Coppée, F., Decleves, A.-E., Laurent, S., & Burtea, C. (21 June 2019). Linking PCSK9 genetic variants with insulin impairment in type 2 diabetes mellitus patients. Paper presented at 2ème Journées Africaines d'Endocrinologie clinique, Abidjan, Côte d’Ivoire. |
 | Andre, S., Atakana Lukulu, J. M., Lecomte, M., Muller, R., Vander Elst, L., Laurent, S., & Burtea, C. (24 May 2019). Development of an original phospholipase A2-targeted peptide able to reduce amyloid pathology in a mouse model of Alzheimer's disease. Poster session presented at 13th National Congress of the Belgian Society for Neuroscience, Brussels, Belgium. doi:10.3389/conf.fnins.2019.96.00032 |
 | TCHEOUBI, S. E. R., Coppée, F., Decleves, A.-E., Laurent, S., AKPOVI, C. D., & Burtea, C. (17 May 2019). PCSK9 gene variants in west - African type 2 diabetes mellitus (T2DM) patients. Poster session presented at Ecole doctorale EDT-BCMB (Biologie Cellulaire et Moléculaire & Biochimie - FNRS), Bruxelles, ULB - Campus Erasme, Belgium. |
 | TCHEOUBI, S. E. R., Andre, S., Laurent, S., & Burtea, C. (18 March 2019). Nouvelle Approche de Ciblage Moléculaire dans le Domaine de la Santé. Poster session presented at Evénement de maillage UMONS-CHU Ambroise Paré (UMHAP), Mons, Belgium. |
 | Derenne, A., Kouakou, C., Belayew, A., Decleves, A.-E., Tassin, A., Burtea, C., & Coppée, F. (08 March 2019). Development of peptides for specific skeletal muscle targeted drug delivery. Poster session presented at 2019 Advances in Skeletal Muscle Biology in Health and Disease, University of Florida, United States - Florida. Editorial reviewed |
TCHEOUBI, S. E. R., AKPOVI, C. D., & Burtea, C. (05 March 2019). Effets des mutations PCSK9 sur le profil lipidique et l'adiponectine chez les patients atteints de diabète de type 2 au Bénin. Poster session presented at Mardi des Chercheurs, Mons, Belgium. |
Burtea, C., Crombez, D., & Laurent, S. (24 December 2018). PEPTIDE AGONISTS OF ADIPONECTIN RECEPTORS 1 AND 2. |
 | Demine, S., Balhuizen, A., Debaille, V., Joosten, L., Fereau, M., Chilla, S. N. M., Millard, I., Scharfmann, R., Egrise, D., Goldman, S., Marchetti, P., Gotthardt, M., Laurent, S., Burtea, C., & Eizirik, D. (21 August 2018). Imaging of Human Insulin Secreting Cells with Gd-DOTA-P88, a Paramagnetic Contrast Agent Targeting the Beta Cell Biomarker FXYD2 gamma-a. Molecules, 23 (9), 2100. doi:10.3390/molecules23092100 Peer reviewed |
Andre, S., Lecomte, M., Muller, R., Vander Elst, L., Laurent, S., & Burtea, C. (07 July 2018). Phospholipase A2 targeting for the development of an original therapeutic strategy in the context of Alzheimer's disease. Paper presented at 11th FENS Forum of Neuroscience, Berlin, Germany. |
Andre, S., Lecomte, M., Muller, R., Vander Elst, L., Laurent, S., & Burtea, C. (28 February 2018). Therapy of Alzheimer's disease: inhibitory potential of a phospholipase A2-targeted peptide able to cross the blood-brain barrier. Poster session presented at Belgian peptide Group Meeting, Bruxelles, Belgium. |
 | Andre, S., Ansciaux, E., Saidi, E., Larbanoix, L., Stanicki, D., Nonclercq, D., Vander Elst, L., Laurent, S., Muller, R., & Burtea, C. (07 November 2017). Validation by magnetic resonance imaging of the diagnostic potential of a heptapeptide-functionalized imaging probe targeted to amyloid beta and able to cross the blood-brain barrier. Journal of Alzheimer's Disease, 60 (4), 1547-1565. doi:10.3233/JAD-170563 Peer Reviewed verified by ORBi |
 | Fanfone, D., Despretz, N., Stanicki, D., Rubio Magnieto, J., Fossepre, M., Surin, M., Rorive, S., Salmon, I., Vander Elst, L., Laurent, S., Muller, R., Saussez, S., & Burtea, C. (2017). Toward a new and noninvasive diagnostic method of papillary thyroid cancer by using peptide vectorized contrast agents targeted to galectin-1. Medical Oncology. Peer Reviewed verified by ORBi |
Burtea, C., Laurent, S., Muller, R., Stanicki, D., Fanfone, D., & Saussez, S. (26 September 2017). Galectin-1 binding peptides and use thereof for diagnostic and therapeutic purpose. |
Derenne, A., Tassin, A., Burtea, C., Decleves, A.-E., & Coppée, F. (13 September 2017). Development of specific molecules using the phage display technology allowing a targeted drug delivery to skeletal muscles in the aim to treat muscular disorders.». Paper presented at Journée PhD day EDT en Sciences Pharmaceutiques, Liège, Belgium. Editorial reviewed |
Andre, S., Daldal, F., Lecomte, M., Muller, R., Vander Elst, L., Laurent, S., & Burtea, C. (22 May 2017). The phospholipase A2 signaling as a new therapeutic biomarker of Alzheimer's disease: modulation through phage display-derived peptides able to cross the blood-brain barrier. Poster session presented at 12th Meeting of the Belgian Neutoscience Society, Ghent, Belgium. doi:10.3389/conf.fnins.2017.94.00057 |
Andre, S., Daldal, F., Delcroix, M., Verteneuil, S., Muller, R., Vander Elst, L., Laurent, S., & Burtea, C. (16 May 2017). Blood-brain barrier crossing for improving brain access using a peptide able to bind a receptor-mediated transcytosis. Paper presented at BMIC, Bruxelles, Belgium. |
Andre, S., Daldal, F., Delcroix, M., Muller, R., Vander Elst, L., Laurent, S., & Burtea, C. (10 April 2017). Towards the therapy of Alzheimer's disease via the inhibition of a phospholipase A2 isoform using peptides able to cross the blood-brain barrier. Poster session presented at BNA 2017 : festival of neuroscience, Birmingham, United Kingdom. |
Fanfone, D., Paternoster, Q., Stanicki, D., Fossepre, M., Surin, M., Rorive, S., Vander Elst, L., Laurent, S., Muller, R., Saussez, S., & Burtea, C. (16 March 2017). Imaging of papillary thyroid cancer using peptide vectorized iron oxide nanoparticles targeted to galectin-1 [Paper presentation]. 3rd Belgium Molecular Imaging Congress, Bruxelles, Belgium. |
Andre, S., Daldal, F., Delcroix, M., Muller, R., Vander Elst, L., Laurent, S., & Burtea, C. (07 March 2017). Targeting phospholipase A2 for the treatment of Alzheimer's disease through a peptidic modulation. Poster session presented at MDC : Mardi des Chercheurs 2017, Mons, Belgium. |
Fanfone, D., Stanicki, D., Fossepre, M., Surin, M., Rorive, S., Vander Elst, L., Laurent, S., Muller, R., Saussez, S., & Burtea, C. (07 March 2017). Development of peptide vectorized contrast agents targeting galectin-1 in the context of imaging diagnosis of papillary thyroid cancer [Poster presentation]. Mardi des Chercheurs (MdC2017), Mons, Belgium. |
 | Balas, M., Ciobanu, C. S., Burtea, C., Stan, M. S., Bezirtzoglou, E., Predoi, D., & Dinischiotu, A. (21 February 2017). Characterization, and Toxicity Evaluation of Dextran - Coated Iron Oxide Nanoparticles. Metals, 7 (2), 63-80. doi:10.3390/met7020063 Peer reviewed |
Andre, S., Daldal, F., Delcroix, M., Muller, R., Vander Elst, L., Laurent, S., & Burtea, C. (10 December 2016). Phospholipase A2 modulation in Alzheimer's disease: new approach of treatment using peptides able to accede to the brain through the LDL receptor. Poster session presented at Joint meeting of the Belgian Neurological Society and Belgian Dementia Council (BeDeCo) December 10th 2016, Antwerp, University of Antwerp, Belgium. |
Fanfone, D., Stanicki, D., Fossepre, M., Surin, M., Rorive, S., Vander Elst, L., Laurent, S., Muller, R., Saussez, S., & Burtea, C. (08 December 2016). Papillary thyroid cancer diagnostic by galectin-1 targeting using peptide vectorized contrast agent for MRI [Paper presentation]. Séminaire des chercheurs Télévie 2017, Woluwé, Belgium. |
Andre, S., Ansciaux, E., Larbanoix, L., Fanfone, D., Nonclercq, D., Vander Elst, L., Laurent, S., Muller, R., & Burtea, C. (29 November 2016). Targeting amyloid plaques for the early diagnosis of Alzheimer's disease: validation of a vectorized superparamagnetic contrast agent able to cross the blood-brain barrier. Poster session presented at BMIC 'Imaging in Drug Discovery and development', Janssen Pharmaceutica, Beerse, Belgium. |
 | Burtea, C., Laurent, S., Sanli, T., Fanfone, D., Devalckeneer, A., Sauvage, S., Beckers, M.-C., Rorive, S., Salmon, I., Vander Elst, L., Lauwerys, B. R., & Muller, R. (10 November 2016). Screening for peptides targeted ti IL-7Ralpha for molecular imaging of rheumatoid arthritis synovium. Arthritis Research and Therapy, 18 (230). doi:10.1186/s13075-016-1133-8 Peer Reviewed verified by ORBi |
Andre, S., Daldal, F., Delcroix, M., Muller, R., Vander Elst, L., Laurent, S., & Burtea, C. (08 October 2016). New therapeutic management of Alzheimer's disease: interest to a phospholipase A2-targeted peptide able to cross the blood-brain barrier through the LDL receptor. Poster session presented at Belgian Brain Congress, MICX. October 8, 2016, Mons, Belgium. doi:10.3389/conf.fnagi.2016.03.00046 |
Fanfone, D., Despretz, N., Stanicki, D., Laurent, S., Muller, R., Rorive, S., Vander Elst, L., Saussez, S., & Burtea, C. (03 September 2016). Study of novel galectin-1 targeted peptides in the context of a new and non-invasive papillary thyroid cancer diagnosis and evaluation of their potential inhibitor effect [Poster presentation]. 39th annual meeting of the european thyroid association, Copenhague, Denmark. |
 | Dentamaro, M., Lux, F., Vander Elst, L., Dauguet, N., Montante, S., Moussaron, A., Burtea, C., Muller, R., Tillement, O., & Laurent, S. (09 June 2016). Chemical and in vitro characterizations of a promising bimodal AGuIX probe able to target apoptotic cells for applications in MRI and optical imaging. Contrast Media and Molecular Imaging, 11, 381-395. doi:10.1002/cmmi.1702 Peer Reviewed verified by ORBi |
Andre, S., Verteneuil, S., Delcroix, M., Muller, R., Vander Elst, L., Laurent, S., & Burtea, C. (08 June 2016). Stratégie thérapeutique de la maladie d'Alzheimer par délivrance ciblée et modulation peptidique d'une phospholipase. Poster session presented at 13ème RFMASA Réunion francophone sur la maladie d'Alzheimer et les syndromes apparentés. 8 au 10 juin 2016, Lyon, France. |
Crombez, D., Vander Elst, L., Muller, R., & Burtea, C. (18 May 2016). Nouvelle stratégie thérapeutique du diabète de type 2 : activation de la voie AMPK via un agoniste peptidique des récepteurs de l'adiponectine. Poster session presented at 9ème édition de la Matinée des Chercheurs 2016 (MdC2016), Valenciennes, France. |
Andre, S., Daldal, F., Delcroix, M., Muller, R., Vander Elst, L., Laurent, S., & Burtea, C. (18 May 2016). Approche thérapeutique de la maladie d'Alzheimer : passage de la barrière hémato-encéphalique et modulation peptidique d'une phospholipase A2. Poster session presented at 9ème édition de la Matinée des Chercheurs 2016 (MdC2016); Mons; Belgique; 2015, Valenciennes, France. |
Fanfone, D., Stanicki, D., Laurent, S., Rorive, S., Saussez, S., Vander Elst, L., Muller, R., & Burtea, C. (18 May 2016). Approche diagnostique non invasive du cancer thyroïdien à l'aide de peptides ciblant la galectine-1 à potentiel anti-cancéreux [Poster presentation]. 9ème édition de la Matinée des Chercheurs 2016 (MdC2016), Valenciennes, France. |
Crombez, D., Muller, R., & Burtea, C. (04 May 2016). Potential therapeutic peptides targeted to adiponectin receptors, able to modulate the AMPK pathway and regulate the glucose and lipid metabolism. Paper presented at Diabetes Kongress, Berlin, Germany. |
Crombez, D., Muller, R., & Burtea, C. (04 May 2016). Potential therapeutic peptides targeted to adiponectin receptors, able to modulate the AMPK pathway and regulate the glucose and lipid metabolism. Poster session presented at Diabetes Kongress, Berlin, Germany. |
Crombez, D., Muller, R., & Burtea, C. (17 February 2016). Type 2 diabetes and metabolic syndrome : agonist peptides targeted to adiponectin receptors are new therapeutic strategy by activation of AMPK pathway. Poster session presented at Belgian Peptide Group Meeting, Bruxelles, Belgium. |
Andre, S., Verteneuil, S., Delcroix, M., Muller, R., Vander Elst, L., Laurent, S., & Burtea, C. (17 February 2016). Peptide-mediated modulation of a phospholipase isoform and blood-brain barrier transcytosis in the context of Alzheimer's disease therapy. Poster session presented at Belgian Peptide Group Meeting, Bruxelles, Belgium. |
Fanfone, D., Despretz, N., Stanicki, D., Laurent, S., Muller, R., Rorive, S., Vander Elst, L., Saussez, S., & Burtea, C. (17 February 2016). Effects of novel galectin-1-targeted peptides on human cells in the context of a new and non-invasive thyroid cancer diagnosis [Poster presentation]. Belgian Peptide Group Meeting, Bruxelles, Belgium. |
 | Rossez, Y., Burtea, C., Laurent, S., Gosset, P., Renaud, L., Gonzalez, W., Ballet, S., Raynal, I., Rousseaux, O., Dugué, T., Vander Elst, L., Michalski, J.-C., Muller, R., & Robbe-Masselot, C. (14 January 2016). Early detection of colonic dysplasia by magnetic resonance molecular imaging with a contrast agent raised against the colon cancer marker MUC5AC. Contrast Media and Molecular Imaging, 11 (3), 211-221. doi:10.1002/cmmi.1682 Peer Reviewed verified by ORBi |
Deruche-Lienard, A., Burtea, C., & Laurent, S. (2016). Diagnostic spécifique du cancer thyroïdien papillaire à l'aide d'un agent de contraste IRM ciblant la galectine-I. Unpublished master thesis, Université de Mons. Jury: . |
| Fanfone, D., Despretz, N., Laurent, S., Arcolia, V., Muller, R., Vander Elst, L., Saussez, S., & Burtea, C. (11 December 2015). Galectin-1, a potential molecular imaging biomarker of well-differentiated thyroid cancers [Poster presentation]. Bioforum-bioliege, Liège, Belgium. |
| Fanfone, D., Despretz, N., Stanicki, D., Laurent, S., Muller, R., Rorive, S., Vander Elst, L., Saussez, S., & Burtea, C. (03 December 2015). Development of a galectin-1 targeted contrast agent for the MRI diagnosis of papillary thyroid cancer [Poster presentation]. Televie's researchers seminar : towards new therapies for cancer patients, Gembloux, Belgium. |
 | Fanfone, D., Despretz, N., Stanicki, D., Laurent, S., Muller, R., Vander Elst, L., Saussez, S., & Burtea, C. (03 October 2015). Development of a new diagnosis approach by MRI of papillary thyroid cancer using a vectorized contrast agent directed against galectin-1 [Poster presentation]. ESMRMB 2015 32th annual scientific meeting, Edimbourg, United Kingdom. |
Ansciaux, E., Burtea, C., Laurent, S., Crombez, D., Nonclercq, D., Vander Elst, L., & Muller, R. (05 June 2015). In vitro and in vivo characterization of several functionalized USPIO vectorized against amyloid plaques and potentially able to cross the blood-brain barrier: toward earlier diagnosis of Alzheimer's disease by molecular imaging. Contrast Media and Molecular Imaging, 10 (3), 211-224. doi:10.1002/CMMI.1626 Peer Reviewed verified by ORBi |
Crombez, D., Scaux, G., Muller, R., & Burtea, C. (22 May 2015). A metabolic therapy of Type 2 Diabetes : AMPK activation by agonist peptides targeted to adiponectin receptors. Poster session presented at Journée d'études UMHAP - from lab to bedside, UMONS, Belgium. |
Andre, S., Verteneuil, S., Delcroix, M., Muller, R., Vander Elst, L., Laurent, S., & Burtea, C. (22 May 2015). Development of a new therapeutic approach for Alzheimer's disease by phospholipase pathway modulation and blood-brain barrier shuttling. Paper presented at 11th National Congress of the Belgian Society for Neuroscience, Mons, Belgium. doi:10.3389/conf.fnins.2015.89.00068 |
 | Fanfone, D., Despretz, N., Laurent, S., Arcolia, V., Muller, R., Vander Elst, L., Saussez, S., & Burtea, C. (22 May 2015). Galectin-1, a potential molecular imaging biomarker of well-differentiated thyroid cancers [Poster presentation]. Première Journée d'Etudes UMHAP, Mons, Belgium. |
Crombez, D., Scaux, G., Muller, R., & Burtea, C. (13 May 2015). A metabolic therapy of Type 2 Diabetes : AMPK activation by agonist peptides targeted to adiponectin receptors. Poster session presented at Bioforum 2015- ULG, Liège, Belgium. |
 | Ansciaux, E., Burtea, C., Laurent, S., Nonclercq, D., Vander Elst, L., & Muller, R. (2015). In vitro and in vivo characterization of several functionalized ultrasmall particles of iron oxide, vectorized against amyloid plaques and potentially able to cross the blood-brain barrier: toward earlier diagnosis of Alzheimer's disease by molecular imaging. Contrast Media and Molecular Imaging. Peer Reviewed verified by ORBi |
Fanfone, D., Despretz, N., Laurent, S., Arcolia, V., Muller, R., Vander Elst, L., Saussez, S., & Burtea, C. (22 April 2015). Well-differentiated thyroid cancer diagnostic imaging: development of a non-invasive method by peptidic targeting of galectin-1 [Paper presentation]. Belgium Molecular Imaging Community Congress, Bruxelles, Belgium. |
Crombez, D., Scaux, G., Muller, R., & Burtea, C. (10 March 2015). Development of an Adiponectin Receptor Agonist for the Metabolic Therapy of Type 2 Diabetes. Poster session presented at 8ème édition de la Matinée des Chercheurs 2015 (MdC2015), Mons, Belgium. |
Andre, S., Verteneuil, S., Muller, R., Vander Elst, L., Laurent, S., & Burtea, C. (10 March 2015). Toward the development of a therapeutic strategy applied to Alzheimer's disease via phospholipase signaling. Poster session presented at 8ème édition de la Matinée des Chercheurs 2015 (MdC2015), Mons, Belgium. |
Fanfone, D., Despretz, N., Laurent, S., Arcolia, V., Muller, R., Vander Elst, L., Saussez, S., & Burtea, C. (10 March 2015). Specific strategy of thyroïd cancer diagnosis by galectin-1 targeting [Poster presentation]. 8ème édition de la Matinée des Chercheurs 2015 (MdC2015), Mons, Belgium. |
 | Burtea, C., Laurent, S., Crombez, D., Delcambre, S., Sermeus, C., Millard, I., Rorive, S., Flamez, D., Beckers, M.-C., Salmon, I., Vander Elst, L., Eizirik, D., & Muller, R. (18 February 2015). Development of a peptide-functionalized imaging nanoprobe for the targeting of (FXYD2)gamma-a as a highly specific biomarker of pancreatic beta cells. Contrast Media and Molecular Imaging, 10 (5), 398-412. doi:10.1002/cmmi.1641 Peer Reviewed verified by ORBi |
Fanfone, D., Despretz, N., Laurent, S., Arcolia, V., Muller, R., Vander Elst, L., Saussez, S., & Burtea, C. (31 January 2015). Toward the development of a galectin-1 targeted imaging probe as a useful tool for the thyroid cancer diagnosis [Poster presentation]. ABEC-BVSK Annual meeting (BACR), UCL Woluwé, Belgium. |
Crombez, D., Laurent, S., Scaux, G., Vander Elst, L., Muller, R., & Burtea, C. (16 January 2015). Development of a molecular approach for the monitoring and treatment of diabetic patients. Poster session presented at 7th annual meeting ISMRM Benelux, Ghent, Belgium. |
Fanfone, D., Despretz, N., Arcolia, V., Muller, R., Vander Elst, L., Saussez, S., & Burtea, C. (16 January 2015). Thyroid cancer imaging :peptidic targeting of galectin-1 as a diagnostic tool [Poster presentation]. 7th annual meeting ISMRM Benelux, Ghent, Belgium. |
| Fanfone, D., Despretz, N., Laurent, S., Arcolia, V., Muller, R., Vander Elst, L., Saussez, S., & Burtea, C. (16 January 2015). Thyroid cancer imaging :peptidic targeting of galectin-1 as a diagnostic tool [Poster presentation]. 7th annual meeting ISMRM Benelux, Ghent, Belgium. |
Methnani, I., Burtea, C., & Laurent, S. (2015). Influence du substrat sur le comportement cellulaire - Etude de l'endocytose de nanoparticules d'oxyde de fer. Unpublished master thesis, Université de Mons. Jury: . |
 | Fanfone, D., Despretz, N., Laurent, S., Arcolia, V., Muller, R., Vander Elst, L., Saussez, S., & Burtea, C. (30 November 2014). Peptidic targeting of galectin-1 as a useful tool in the thyroid cancer diagnosis [Paper presentation]. EDT-Cancérologie expérimentale:annual mini symposium 'From clinic to lab and vice versa', Liège, Belgium. |
 | Crombez, D., Scaux, G., Muller, R., & Burtea, C. (18 November 2014). Thérapie métabolique des troubles liés au diabète de type 2 via le développement d'un agoniste du récepteur de l'adiponectine. Poster session presented at Biomarqueurs d'imagerie du métabolisme et du risque cardio-vasculaire, Lyon, France. |
 | Zghikh, L., Vangysel, E., Nonclercq, D., Legrand, A., Blairon, B., Berri, C., Bordeau, T., Rémy, C., Burtea, C., Montuelle, S., & Bels, V. (02 September 2014). Morphology and fiber-type distribution in the tongue of the Pogona vitticeps lizard (Iguania: Agamidae). Journal of Anatomy, 225 (4), 377-389. Peer Reviewed verified by ORBi |
Ansciaux, E., Burtea, C., Laurent, S., Vander Elst, L., Nonclercq, D., & Muller, R. (13 June 2014). Un agent de contraste vectorisé contre les plaques amyloïdes et potentiellement capable de franchir la barrière hémato-encéphalique : vers un diagnostic précoce de la maladie d'Alzheimer par imagerie de résonance magnétique. Paper presented at 12ème Réunion Francophone sur la Maladie d'Alzheimer et les syndromes apparentés, Montpellier, France. |
 | Crombez, D., Delcambre, S., Muller, R., & Burtea, C. (10 February 2014). Development of a peptide agonist of adiponectin receptor for the therapy of type 2 diabetes and metabolic syndrome. Poster session presented at Belgian Peptide Meeting, Ghent, Belgium. |
| Ansciaux, E., Burtea, C., Laurent, S., Vander Elst, L., Nonclercq, D., & Muller, R. (10 February 2014). A contrast agent vectorized against amyloid plaques and potentially able to cross the blood-brain barrier: toward earlier diagnosis of Alzheimer's disease by molecular imaging. Poster session presented at Belgian Peptide Meeting, Ghent, Belgium. |
 | Mao, H., Chen, W., Laurent, S., Thirifays, C., Burtea, C., Rezaee, F., & Mahmoudi, M. (24 July 2013). Hard Corona Composition and Cellular Toxicities of the Graphene Sheets. Colloids and Surfaces B: Biointerfaces, 109, 212-218. Peer Reviewed verified by ORBi |
Radu, M., Burtea, C., Predoi, D., & Muller, R. (06 July 2013). Toxicological aspects of PANC-1 cells exposure to iron oxide dextran-covered nanoparticles. Paper presented at The 38th FEBS Congress, Saint Petersburg, Russia. |
Radu, M., Burtea, C., Predoi, D., Muller, R., & Dinischiotu, A. (06 July 2013). Toxicological aspects of PANC -1 cells exposure to iron oxide dextran - coated nanoparticles. Paper presented at The 38th FEBS Congress, Saint Petersburg, Russia. |
Muller, R., Vander Elst, L., Laurent, S., & Burtea, C. (28 May 2013). The design of nanoparticles for molecular imaging: a multidisciplinary task. Paper presented at E-MRS 2013 SPRING MEETING, SPRING 13 U: Design of multifunctional nano-objects for biomedical applications, Strasbourg, France. |
Muller, R., Vander Elst, L., Laurent, S., & Burtea, C. (27 May 2013). The design of nanoparticles for molecular imaging: a multidisciplinary task. Paper presented at E-MRS 2013 SPRING MEETING, SPRING 13 U: Design of multifunctional nano-objects for biomedical applications, Strasbourg, France. |
Ansciaux, E., Burtea, C., Nonclercq, D., Vander Elst, L., Laurent, S., & Muller, R. (26 May 2013). A contrast agent vectorized against amyloid plaques and potentially able to cross the blood-brain barrier: toward earlier diagnosis of Alzheimer's disease by molecular imaging. Paper presented at 8th Annual Meeting of the European Society of Molecular Imaging, Torino, Italy. |
Burtea, C., Laurent, S., Vander Elst, L., & Muller, R. (26 May 2013). Development of molecular imaging tools for the monitoring of diabetic patients. Paper presented at 8th Annual Meeting of the European Society of Molecular Imaging, Torino, Italy. |
 | Crombez, D., Burtea, C., & Muller, R. (24 May 2013). Therapy of type 2 diabetes: development of an agonist of adiponectin receptor. Poster session presented at 1st Health Institute Day, Mons, Belgium. |
Ansciaux, E., Burtea, C., Nonclercq, D., Vander Elst, L., Laurent, S., & Muller, R. (24 May 2013). USPIO-PHO: a new vectorized contrast agent for early Diagnosis of Alzheimer's disease By molecular imaging. Poster session presented at 1st Health Institute Day, Mons, Belgium. |
den Adel, B., Suidgeest, E., Burtea, C., van der Heiden, K., Stammes, M. A., Laurent, S., Gijsen, F., Muller, R., Poelmann, R. E., & Van der Weerd, L. M. (24 May 2013). Vascular cell adhesion molecule-1 targeted nanoparticles discriminate between atherosclerotic plaque stages in disease progression and therapy. Paper presented at 8th annual meeting of the European Society for Molecular Imaging, ESMI, Turin, Italy. |
den Adel, B., Suidgeest, E., Burtea, C., Stammes, M. A., van der Heiden, K., Laurent, S., Poelmann, R. E., Muller, R., & Van der Weerd, L. M. (24 May 2013). E-selectin targeted MRI visualizes progression of atherosclerotic plaques. Paper presented at 8th annual meeting of the European Society for Molecular Imaging, ESMI, Turin, Italy. |
 | Laurent, S., Ng, E.-P., Thirifays, C., Lakiss, L., Goupil, J., Mintova, S., Burtea, C., Oveisi, E., Hebert, C., Vries, M., Motazacker, M., Rezaee, F., & Mahmoudi, M. (25 April 2013). Corona protein composition and cytotoxicity evaluation of ultra-small zeolites synthesized from template free precursor suspensions. Toxicology Research, 2, 270-279. Peer reviewed |
den Adel, B., Suidgeest, E., Burtea, C., Stammes, M. A., van der Heiden, K., Laurent, S., Poelmann, R. E., Muller, R., & Van der Weerd, L. M. (20 April 2013). E-selectin targeted USPIO enhancement of atherosclerotic plaques visualizes treatment response and mechanism of action. Paper presented at 21ème congrès de l'ISMRM, Salt Lake City, United States - Utah. |
Ansciaux, E., Burtea, C., Nonclercq, D., Vander Elst, L., Laurent, S., & Muller, R. (06 March 2013). Alzheimer's disease : new promising vectorized contrast agents for early diagnosis and evaluation of future therapeutic strategies using magnetic resonance imaging. Paper presented at International Congress Alzheimer's Disease/Parkinson's Disease 2013, Florence, Italy. |
 | Laurent, S., Burtea, C., Thirifays, C., Rezaee, F., & Mahmoudi, M. (15 February 2013). Significance of cell ''observer' and protein source in nanobiosciences. Journal of Colloid and Interface Science, 392, 431. Peer Reviewed verified by ORBi |
 | Sclavons, C., Burtea, C., Boutry, S., Laurent, S., Vander Elst, L., & Muller, R. (04 February 2013). Phage display screening for tumor necrosis factor-alpha-binding peptides. Detection of inflammation in a mouse model of hepatitis. International Journal of Peptides, 2013, 9. doi:10.1155/2013/348409 Peer Reviewed verified by ORBi |
Ansciaux, E., Burtea, C., Nonclercq, D., Vander Elst, L., Laurent, S., & Muller, R. (29 January 2013). Alzheimer's disease : new promising vectorized contrast agents for early diagnosis and evaluation of future therapeutic strategies using magnetic resonance imaging. Poster session presented at Journée Scientifique des Doctorants en Sciences biomédicales et pharmaceutiques; New tools and strategies in the identification of pathology-related biomarkers, Mons, Belgium. |
 | Laurent, S., Ng, E., Thirifays, C., Lakiss, L., Goupil, J., Mintova, S., Burtea, C., Oveisi, E., Hebert, C., Vries, M., Motazacker, M., Rezaee, F., & Mahmoudi, M. (2013). Corona protein composition and cytotoxicity evaluation of ultrasmall zeolites synthesized from template free precursor suspensions. Toxicology Research. Peer reviewed |
Muller, R., Eizirik, D., Sermeus, C., Laurent, S., Burtea, C., Beckers, M.-C., & Flamez, D. (27 December 2012). Molecules specifically binding pancreatic beta cells biomarkers. |
Burtea, C., Laurent, S., Muller, R., Sermeus, C., & Eizirik, D. (26 December 2012). Molecules specifically binding pancreatic beta cells biomarkers. |
 | Mahmoudi, M., Saeedi-Eslami, S.-E., Shokrgozar, M. A., Azadmanesh, K., Hasanloo, M., Kalhor, H., Burtea, C., Rothen-Rutishauser, B., Laurent, S., Sheibani, S., & Vali, H. (03 December 2012). Cell 'vision': complementary factor of protein corona in nanotoxicology. Nanoscale, 4 (17), 5461-5468. Peer Reviewed verified by ORBi |
den Adel, B., Burtea, C., Laurent, S., Suidgeest, E., Poelmann, R. E., Muller, R., & Van der Weerd, L. M. (30 November 2012). Stageing of atherosclerotic plaques by a vascular cell adhesion protein-1 targeted contrast agent. Poster session presented at Fourth annual meeting of the ISMRM Benelux, Leuven, Belgium. |
denAdel, B., Burtea, C., Laurent, S., Suidgeest, E., Poelmann, R. E., Muller, R., & van der Weerd, L. (05 September 2012). Imaging Anti-Atherosclerotic Therapy Response and macrophage polarization in ApoE-/- Mice Using E-selectin Targeted USPIOs. Poster session presented at World Molecular Imaging Congress, Dublin, Ireland. |
denAdel, B., Burtea, C., Suidgeest, E., Laurent, S., Poelmann, R. E., Muller, R., & van der Weerd, L. (05 September 2012). Molecular MRI of Atherosclerosis and Anti-Atherosclerotic Therapy Outcome by a Vascular Cell Adhesion Molecule-1 Targeted Contrast Agent. Poster session presented at World Molecular Imaging Congress, Dublin, Ireland. |
Burtea, C. (2012). Biologie, y compris les éléments de génétique humaine, Syllabus. |
Ansciaux, E., Burtea, C., Vander Elst, L., Laurent, S., & Muller, R. (17 June 2012). Développement de nouveaux agents de contraste vectorisés destinés au diagnostic par IRM de la maladie d'Alzheimer. Poster session presented at Doctoriales Franco-Belges, Mont Saint-Aubert, Belgium. |
 | Verwilst, P., Eliseeva, S., Vander Elst, L., Burtea, C., Laurent, S., Petoud, S., Muller, R., Parac-Vogt, T. N., & De Borggraeve, W. M. (04 June 2012). A Tripodal Ruthenium-Gadolinium Metallostar as a Potential a(v)ß(3) Integrin Specific Bimodal Imaging Contrast Agent. Inorganic Chemistry, 51 (11), 6405-6411. doi:10.1021/ic300717m Peer Reviewed verified by ORBi |
 | Ansciaux, E., Burtea, C., Laurent, S., Vander Elst, L., & Muller, R. (22 May 2012). Développement de nouveaux agents de contraste vectorisés destinés au diagnostic par IRM de la maladie d'Alzheimer. Poster session presented at 11ème Réunion sur la Maladie d'Alzheimer et les Symptomes Apparentés, Toulouse, France. |
 | Burtea, C., Ballet, S., Laurent, S., Rousseaux, O., Dencausse, A., Gonzalez, W., Port, M., Corot, C., Vander Elst, L., & Muller, R. (19 April 2012). Development of a magnetic resonance imaging protocol for the characterization of atherosclerotic plaque by using vascular cell adhesion molecule-1 and apoptosis targeted ultrasmall superparamagnetic iron oxide derivatives. Arteriosclerosis, Thrombosis, and Vascular Biology, 32 (6), 36-48. Peer reviewed |
 | Arsalani, N., Fattahi, H., Laurent, S., Burtea, C., Vander Elst, L., & Muller, R. (04 February 2012). Polyglycerol-grafted superparamagnetic iron oxide nanoparticles: highly efficient MRI contrast agent for liver and kidney imaging and potential scaffold for cellular and molecular imaging. Contrast Media and Molecular Imaging, 7, 185-194. Peer Reviewed verified by ORBi |
 | Laurent, S., Burtea, C., Thirifays, C., Häfeli, U. O., & Mahmoudi, M. (10 January 2012). The Importance of toxicity assay modifications and 'Cell Vision'. PLoS ONE, 7 (1), 29997. doi:10.1371/journal.pone.0029997 Peer reviewed |
 | Burtea, C., Laurent, S., Lancelot, E., Rousseaux, O., Ballet, S., Thirifays, C., Port, M., Toubeau, G., Vander Elst, L., Corot, C., & Muller, R. (22 November 2011). Development and validation of a peptide-vectorized superparamagnetic imaging probe designed for the detection of inflammation in atherosclerotic plaque. Poster session presented at 4ème Journée Scientifique du Pôle Hainuyer 'Arts et Sciences', HEH, Mons, Belgium. |
Ansciaux, E., Burtea, C., Laurent, S., Vander Elst, L., & Muller, R. (06 October 2011). In vitro and in vivo characterization of several functionalized USPIO derivatives designed for molecular MRI of Alzheimer's disease. Poster session presented at 28th Annual Meeting of the European Society for Magnetic Resonance in Medicine and Biology, Leipzig, Germany. |
 | Fattahi, H., Arsalani, N., Laurent, S., Burtea, C., Vander Elst, L., & Muller, R. (05 September 2011). Preparation of novel polyglycerol-iron oxide hybrid nanoparticles as high efficient MRI contrast agent for liver and kidney imaging. Poster session presented at IUPAC 9th International Conference on Advanced Polymers Via Macromolecular Engineering, Cappadocia, Turkey. |
Rossez, Y., Laurent, S., Burtea, C., Gossez, P., Mouray, A., Chassat, T., Dugué, T., Rousseaux, O., Gonzalez, W., Ballet, S., Raynal, I., Muller, R., Michalski, J.-C., & Robbe-Masselot, C. (09 July 2011). Identification of peptidic ligands targeting MUC5AC for the development of contrast products adapted to the magnetic resonance imaging of human colon cancer. Poster session presented at 11th International Workshop on Carcinoma-associated Mucins, Robinson College, Cambridge, United Kingdom. |
 | Burtea, C., Laurent, S., Mahieu, I., Larbanoix, L., Roch, A., Port, M., Rousseaux, O., Ballet, S., Murariu, O., Toubeau, G., Corot, C., Vander Elst, L., & Muller, R. (01 July 2011). In vitro biomedical applications of functionalized iron oxide nanoparticles, including those not related to magnetic properties. Contrast Media and Molecular Imaging, 6, 236-250. doi:10.1002/cmmi.423 Peer Reviewed verified by ORBi |
 | Laurent, S., Burtea, C., Vander Elst, L., & Muller, R. (01 July 2011). Synthesis and characterization of new low-molecular-weight lysine-conjugated Gd-DTPA contrast agents. Contrast Media and Molecular Imaging, 6 (4), 229-235. doi:10.1002/cmmi.422 Peer Reviewed verified by ORBi |
 | Burtea, C., Laurent, S., Muller, R., Sermeus, C., & Eizirik, D. (23 June 2011). Molecules specifically binding pancreatic beta cells biomarkers. |
Ansciaux, E. A., Burtea, C., Laurent, S., Vander Elst, L., & Muller, R. (19 June 2011). Biological characterization of several functionalized USPIO derivatives designed for the molecular MRI of Alzheimer's disease. Poster session presented at 6th European Molecular Imaging Meeting, ENIM, Leiden, Netherlands. |
den Adel, B., Burtea, C., Laurent, S., Stammes, M. A., Suidgeest, E., Poelmann, R. E., Muller, R., & Van der Weerd, L. M. (19 June 2011). Molecular MR imaging of atherosclerotic plaques by a vascular cell adhesion protein-1 targeted contrast agent. Paper presented at 6th European Molecular Imaging Meeting, ENIM, Leiden, Netherlands. |
 | Larbanoix, L., Burtea, C., Ansciaux, E., Laurent, S., Mahieu, I., Vander Elst, L., & Muller, R. (01 June 2011). Design and evaluation of a 6-mer amyloid-beta protein derived phage display library for molecular targeting of amyloid plaques in Alzheimer's disease: Comparison with two cyclic heptapeptides derived from a randomized phage display library. Peptides, 32 (6), 1232-43. doi:10.1016/j.peptides.2011.04.026 Peer Reviewed verified by ORBi |
 | Larbanoix, L., Burtea, C., Ansciaux, E., Laurent, S., Mahieu, I., Vander Elst, L., & Muller, R. (06 May 2011). Design and evaluation of a 6-mer amyloid-beta protein derived phage display library for molecular targeting of amyloid plaques in Alzheimer's disease. Comparison with two cyclic heptapeptides derived from a randomized phage display library. Peptides, 32(6), 1232-1243. doi:10.1016/j.peptides.2011.04.026 Peer Reviewed verified by ORBi |
Sclavons, C., Burtea, C., Boutry, S., Laurent, S., Toubeau, G., Vander Elst, L., & Muller, R. (07 April 2011). Targeting of inflammation with a phage-display targeting peptide. Poster session presented at Biomedica, Eindhoven, Netherlands. |
 | Kiyofuji, K., Tsunekawa, K., Yamashita, M., Yamashita, J., Fujie, M., Asai, K., Suyama, T., Ito, S., Reddy, V. K., Yamada, M., Ogawa, K., Ozaki, N., Sugiyama, M., Yamaoka, M., Makita, R., Nakamura, S., Aoki, T., Yu, G., Aoshima, K., ... Muller, R. (01 January 2011). Preparation and Evaluation of Novel Sugar Dendritic Gd-DTPA Complexes for MRI Contrast Agents and Phospha Sugars for Anti-tumour Agents. Advanced Materials Research, 222, 217-220. doi:10.4028/www.scientific.net/AMR.222.217 Peer reviewed |
 | VERWILST, P., ELISEEVA, S. V., CARRON, S., Vander Elst, L., Burtea, C., Dehaen, G., Laurent, S., Binnemans, K., Muller, R., Parac-Vogt, T. N., & De Borggraeve, W. M. (2011). A modular approach towards the synthesis of target-specific MRI contras agents. European Journal of Inorganic Chemistry, 3577-3585. doi:10.1002/ejic.201100575 Peer Reviewed verified by ORBi |
 | Burtea, C., Laurent, S., Mahieu, I., Larbanoix, L., Roch, A., Port, M., Rousseaux, O., Ballet, S., Murariu, O., Toubeau, G., Corot, C., Vander Elst, L., & Muller, R. (29 December 2010). In vitro biomedical applications of functionalized iron oxide nanoparticles, including those not related to magnetic properties. Contrast Media and Molecular Imaging, 6 (4), 236-50. doi:10.1002/cmmi.423 Peer Reviewed verified by ORBi |
 | Larbanoix, L., Burtea, C., Laurent, S., Van Leuven, F., Toubeau, G., Vander Elst, L., & Muller, R. (31 October 2010). Potential amyloid plaque-specific peptides for the diagnosis of Alzheimer's disease. Neurobiology of Aging, 31 (10), 1679-89. doi:10.1016/j.neurobiolaging.2008.09.021 Peer Reviewed verified by ORBi |
Yamashita, M., Ozaki, N., Yamashita, J., Fujie, M., Sugiyama, M., Ogawa, K., Aoki, T., Ito, S., Reddy, V. K., Yamada, M., Aoshima, K., Kamikage, N., Ravi Sankar, A. U., Yu, G., Kiyofuji, K., Takehara, Y., Sakahara, H., Takayanagi, H., Laurent, S., ... Muller, R. (19 May 2010). Researches on sugar modified dendritic Gd-DTPA complexes for MRI contrast agents. Paper presented at Contrast-enhanced biomedical imaging, 12th Bi-Annual Conference on Contrast Agents and Multimodal Molecular Imaging, Mons, Belgium. |
 | Burtea, C., Laurent, S., Ballet, S., Port, M., Rousseaux, O., Thirifays, C., Toubeau, G., Vander Elst, L., Corot, C., & Muller, R. (19 May 2010). Development of a robust protocol for vulnerable plaque characterization by using two peptide-functionalized USPIO derivaties. Paper presented at Contrast-enhanced biomedical imaging, 12th Bi-Annual Conference on Contrast Agents and Multimodal Molecular Imaging, Mons, Belgium. |
Sclavons, C., Burtea, C., Laurent, S., Toubeau, G., Vander Elst, L., & Muller, R. (19 May 2010). MRI targeting of apoptotic cells in injured areas of brain in a mouse model of Parkinson's disease. Poster session presented at Contrast-enhanced biomedical imaging, 12th Bi-Annual Conference on Contrast Agents and Multimodal Molecular Imaging, Mons, Belgium. |
Laurent, S., Burtea, C., Rerat, V., Marchand, J., Vander Elst, L., & Muller, R. (01 May 2010). Ultrasmall particle of iron oxide - RGD peptidomimetic conjugate as novel MRI contrast agent. Poster session presented at ISMRM, Stockholm, Sweden. |
 | Burtea, C., Laurent, S., Lancelot, E., Rousseaux, O., Ballet, S., Thirifays, C., Port, M., Toubeau, G., Vander Elst, L., Corot, C., & Muller, R. (01 May 2010). Development and validation of a peptide-vectorized superparamagnetic imaging probe designed for detection of inflammation in atherosclerotic plaque. Poster session presented at ISMRM, Stockholm, Sweden. |
 | Rerat, V., Laurent, S., Burtea, C., Driesschaert, B., Pourcelle, V., Vander Elst, L., Muller, R., & Marchand-Brynaert, J. (15 March 2010). Ultrasmall particle of iron oxide - RGD peptidomimetic conjugate: synthesis and characterization. Bioorganic and Medicinal Chemistry Letters, 20 (6), 1861-1865. doi:10.1016/j.bmcl.2010.01.150 Peer Reviewed verified by ORBi |
 | Laurent, S., Burtea, C., & Boutry, S. (2009). L'imagerie moléculaire, un nouvel outil multidisciplinaire de la recherche biomédicale. |
 | Burtea, C., Laurent, S., Lancelot, E., Port, M., Ballet, S., Rousseaux, O., Vander Elst, L., & Muller, R. (30 May 2009). Molecular MRI of apoptosis in atherosclerotic plaque by using a peptide-vectorized paramagnetic imaging probe. Paper presented at 4th European Molecular Imaging Meeting, Barcelone, Spain. |
Larbanoix, L., Burtea, C., Laurent, S., Toubeau, G., Van Leuven, F., Vander Elst, L., & Muller, R. (28 May 2009). Recherche par phage display et caractérisation de peptides ciblant les plaques amyloïdes de la maladie d'Alzheimer. Poster session presented at 23ème journées franco-belges de pharmacochimie, 'de la conception à la réalisation en pharmacochimie', Université de Mons, Belgium. |
Sclavons, C., Burtea, C., Laurent, S., Toubeau, G., Vander Elst, L., & Muller, R. (01 April 2009). MRI targeting of apoptotic cells in injured areas of brain in a mouse model of Parkinson's disease. Poster session presented at Biomedica, Liège, Belgium. |
Larbanoix, L., Burtea, C., Laurent, S., Van Leuven, F., Toubeau, G., Vander Elst, L., & Muller, R. (01 April 2009). Potential amyloid plaque-specific peptides for the diagnosis of Alzheimer's disease. Poster session presented at Biomedica, Liège, Belgium. |
Yamashita, J., Yamashita, M., Fujie, M., Suyama, K. A. T., Ito, S., Reddy, V. K., Yamada, M., Ogawa, K., Ozaki, N., Nakamura, S., Aoki, T., Yu, G., Aoshima, K., Kato, T., Kamikage, N., Kiyofuji, K., Takehara, Y., Sakahara, H., Takayanagi, H., ... Muller, R. (01 January 2009). R&D of novel medicinal materials for curing cancer: sugar modified Gd-DTPA MRI contrast agents and Phospha Sugar Anti-cancer agents. Journal of Automation, Mobile Robotics and Intelligent Systems, 3 (4), 80-83. Peer Reviewed verified by ORBi |
Burtea, C., Laurent, S., Port, M., Lancelot, E., Ballet, S., Rousseaux, O., Toubeau, G., Vander Elst, L., Corot, C., & Muller, R. (2009). Molecular MRI of VCAM-1 expression in inflammatory lesions by using a peptide-vectorized paramagnetic imaging probe. Journal of Medicinal Chemistry. Peer Reviewed verified by ORBi |
Burtea, C., Laurent, S., Lancelot, E., Ballet, S., Muriariu, O., Rousseaux, O., Port, M., Vander Elst, L., Corot, C., & Muller, R. (2009). Identification of Peptide Ligands that Target Apoptotic Cells by Means of Specific Interactions with Phosphatidylserine. Applications to Molecular Imaging by MRI. Molecular Pharmaceutics. Peer Reviewed verified by ORBi |
 | Boutry, S., Forge, D., Burtea, C., Mahieu, I., Murariu, O., Laurent, S., Vander Elst, L., & Muller, R. (01 January 2009). How to quantify iron in an aqueous or biological matrix: a technical note. Contrast Media and Molecular Imaging, 4 (6), 299-203. doi:10.1002/cmmi.291 Peer Reviewed verified by ORBi |
 | Burtea, C., Laurent, S., Lancelot, E., Ballet, S., Murariu, O., Rousseaux, O., Port, M., Vander Elst, L., Corot, C., & Muller, R. (01 January 2009). Peptidic Targeting of Phosphatidylserine for the MRI Detection of Apoptosis in Atherosclerotic Plaques. Molecular Pharmaceutics, 6 (6), 1903-1919. doi:10.1021/mp900106m Peer Reviewed verified by ORBi |
 | Burtea, C., Laurent, S., Port, M., Lancelot, E., Ballet, S., Rousseaux, O., Toubeau, G., Vander Elst, L., Corot, C., & Muller, R. (01 January 2009). Magnetic Resonance Molecular Imaging of Vascular Cell Adhesion Molecule-1 Expression in Inflammatory Lesions Using a Peptide-Vectorized Paramagnetic Imaging Probe. Journal of Medicinal Chemistry, 52 (15), 4725-4742. doi:10.1093/cvr/cvm115 Peer Reviewed verified by ORBi |
 | Port, M., Rousseaux, O., Muller, R., & Burtea, C. (23 October 2008). Compounds for the diagnosis of diseases associated with VCAM expression. |
Port, M., Rousseaux, O., Muller, R., & Burtea, C. (23 October 2008). Compounds for diagnosing apoptosis. |
 | Port, M., Rousseaux, O., Muller, R., & Burtea, C. (23 October 2008). Compounds for diagnosing apoptosis. |
Port, M., Rousseaux, O., Muller, R., & Burtea, C. (23 October 2008). Compounds for the diagnosis of diseases associated with VCAM expression. |
 | Burtea, C., & Muller, R. (27 September 2008). Imagerie de l'athérosclérose par IRM. Paper presented at IVe Symposium « Lipides et Athérosclérose », Charleroi, Belgium. |
Yamashita, M., Aoki, T., Ito, S., Ogawa, K., Ozaki, N., Fujie, M., Yu, G., Aoshima, K., Sugiyama, M., Kamikage, N., Yamashita, J., Takehara, Y., Sakahara, H., Takayanagi, H., Oshikawa, T., Laurent, S., Burtea, C., Vander Elst, L., & Muller, R. (21 September 2008). Research on cancer finding and chemotherapy at the early stage - syntheses and evaluations of novel sugar-ball-dendrimer MRI contrast agents and pgospha sugars by sugar modification. Paper presented at 11th Bratisvlava Symposium on Saccharides, Smolenice Castle, Slovakia. |
Aoki, T., Yamashita, M., Ogawa, K., Ozaki, N., Fujie, M., Sugiyama, M., Aoshima, K., Mizuno, S., Kamikage, N., Yamashita, J., Yu, G., Krishna Reddy, V., Oshikawa, T., Takehara, Y., Sakahara, H., Laurent, S., Burtea, C., Vander Elst, L., & Muller, R. (21 September 2008). Synthesis and evaluation of chemically-modified novel MRI contrast agents with sugars. Paper presented at 11th Bratisvlava Symposium on Saccharides, Smolenice Castle, Slovakia. |
 | Burtea, C., Laurent, S., Port, M., Lancelot, E., Ballet, S., Murariu, O., Toubeau, G., Vander Elst, L., Corot, C., & Muller, R. (10 September 2008). Molecular imaging of VCAM-1 expression in inflammatory pathologies by using low-molecular weight peptides conjugated to a paramagnetic reporter. Paper presented at World Molecular Imaging Congress, Nice, France. |
 | Larbanoix, L., Burtea, C., Laurent, S., Van Leuven, F., Toubeau, G., Vander Elst, L., & Muller, R. (10 September 2008). Potential amyloid plaque-specific peptides for the diagnosis of Alzheimer's disease. Poster session presented at World Molecular Imaging Congress, Nice, France. |
 | Sclavons, C., Burtea, C., Laurent, S., Toubeau, G., Vander Elst, L., & Muller, R. (07 September 2008). MRI targeting of apoptotic cells in injured areas of brain in a mouse model of Parkinson's disease. Poster session presented at World Molecular Imaging Congress, Nice, France. |
 | Burtea, C., Laurent, S., Vander Elst, L., & Muller, R. (2008). Contrast Agents: magnetic resonance. In Molecular Imaging I (pp. 135-165). Springer. doi:10.1007/978-3-540-72718-7_7 |
Yamashita, M., Aoki, T., Ogawa, K., Ozaki, N., Fujie, M., Yamashita, J., Aoshima, K., Kamikage, N., Yu, G., Oshikawa, T., Takehara, Y., Sakahara, H., Laurent, S., Burtea, C., Vander Elst, L., & Muller, R. (03 July 2008). Construction of DDS of Gd-DTPA Complex with Sugar Ball Dendrimer for Drawing Blood Vessels and Tumors by MRI. Poster session presented at International Conference on Organometallic Chemistry, Rennes, France. |
Sclavons, C., Burtea, C., Laurent, S., Murariu, O., Toubeau, G., Vander Elst, L., & Muller, R. (01 January 2008). Ciblage IRM de l'apoptose dans les zones lésées dans la maladie de Parkinson. Poster session presented at Congrès du GRAMM, Lyon, France. |
 | Burtea, C., Laurent, S., Murariu, O., Rattat, D., Toubeau, G., Verbruggen, A., Vansthertem, D., Vander Elst, L., & Muller, R. (01 January 2008). Molecular imaging of alpha(v)beta(3) integrin expression in atherosclerotic plaques with a mimetic of RGD peptide grafted to Gd-DTPA. Cardiovascular Research, 78 (1), 148-157. doi:10.1093/cvr/cvm115 Peer Reviewed verified by ORBi |
 | Burtea, C., Corot, C., Laurent, S., Port, M., Lancelot, E., Ballet, S., Vander Elst, L., & Muller, R. (14 June 2007). Research of phage display-selected peptides with specific affinity for Vascular Cell Adhesion Molecule-1 (VCAM-1) overexpressed in atherosclerotic plaques. Poster session presented at International Conference of the European Society of Molecular Imaging, Naples, Italy. |
 | Yu, G., Yamashita, M., Aoshima, K., Takahashi, M., Oshikawa, T., Takayanagi, H., Laurent, S., Burtea, C., Vander Elst, L., & Muller, R. (2007). A glycosylated complex of gadolinium, a new potential contrast agent for magnetic resonance angiography ? Bioorganic and Medicinal Chemistry Letters. Peer Reviewed verified by ORBi |
Larbanoix, L., Burtea, C., Laurent, S., Murariu, O., Vansthertem, D., Toubeau, G., Van Leuven, F., Vander Elst, L., & Muller, R. (01 January 2007). In vitro characterization of Ab42 specific heptapeptides selected by phage display and preliminary studies on Alzheimer's disease diagnosis by MRI with peptide functionalized contrast agents. Poster session presented at European Society for molecular imaging, Second International Conference, (ESMI), Naples, Italy. |
Ogawa, K., Ozaki, N., Fujie, M., Yamashita, M., Yu, G., Aoshima, K., Kobayashi, M., Kato, T., Kamikage, N., Aoki, T., Takayanagi, H., Oshikawa, T., Takehara, Y., Sakahara, H., Laurent, S., Burtea, C., Vander Elst, L., & Muller, R. (01 January 2007). Studies on novel MRI contrast agents for specific organs, blood vessels, and tumors. Poster session presented at 14th European Carbohydrate Symposium - Eurocarb 14, Lubeck, Germany. |
 | Segers, J., Laumonier, C., Burtea, C., Laurent, S., Vander Elst, L., & Muller, R. (01 January 2007). From phage display to magnetophage, a new tool for magnetic resonance molecular imaging. Bioconjugate Chemistry, 18 (4), 1251-1258. doi:10.1021/bc060377f Peer Reviewed verified by ORBi |
 | Yu, G., Yamashita, M., Aoshima, K., Kobayashi, M., Kato, T., Kamikage, N., Takahashi, M., Takayanagi, H., Oshikawa, T., Laurent, S., Burtea, C., Vander Elst, L., Muller, R., Takehara, Y., & Sakahara, H. (01 January 2007). Studies on preparation and characterization of novel MRI contrast agents for targeting organs and blood vessels. Heterocyclic Communications, 13 (2-3), 101-108. Peer Reviewed verified by ORBi |
 | Yu, G., Yamashita, M., Aoshima, K., Takahashi, M., Oshikawa, T., Takayanagi, H., Laurent, S., Burtea, C., Vander Elst, L., & Muller, R. (01 January 2007). A glycosylated complex of gadolinium, a new potential contrast agent for magnetic resonance angiography? Bioorganic and Medicinal Chemistry Letters, 17 (8), 2246-2249. doi:10.1016/j.bmcl.2007.01.067 Peer Reviewed verified by ORBi |
Yamashita, M., Ito, S., Hu, G., Fujé, M., Taishi, N., Sakara, Y., Ogawa, K., Kasthuraiah, M., Ogawa, T., Otake, Y., Asai, S., Aoki, S., Hara, Y., Aoshima, K., Kobayashi, M., Kamikage, N., Takahashi, M., Takayanagi, H., Oshikawa, T., ... Muller, R. (10 December 2006). Some recent approaches towards innovation of cancer therapy. Improvement of QOL of patients and novel materials for early stage findings and madical treatments for tumors by collaboration of medical sciences and engineering. Poster session presented at The 5th International Conference on Global Research and Education, Proceedings, Iasi, Romania. |
Yamashita, M., Ito, S., Hu, G., Fujie, M., Taishi, N., Sakata, Y., Ogawa, K., Ozaki, N., Kasthuraiah, M., Ogawa, T., Otake, Y., Asai, K., Aoki, S., Hara, Y., Aoshima, K., Kobayashi, M., Kamikage, N., Takahashi, M., Takayanagi, H., ... Muller, R. (25 September 2006). Some recent approaches towards innovation of cancer therapy. Improvement of QOL of patients and novel materials for early stage findings and madical treatments for tumors by collaboration of medical sciences and engineering. Paper presented at 5th International Conference on Global Research and Education, Iasi, Romania. |
 | Burtea, C., Laurent, S., Vander Elst, L., Toubeau, G., & Muller, R. (15 September 2006). Molecular imaging of angiogenic blood vessels in vulnerable atherosclerotic plaques with a mimetic of RGD peptide grafted to Gd-DTPA. Poster session presented at Annual Meeting of the European Society for Magnetic Resonance in Medicine and Biology, Varsovie, Poland. |
 | Larbanoix, L., Burtea, C., Laurent, S., Vansthertem, D., Toubeau, G., Van Leuven, F., Vander Elst, L., & Muller, R. (15 September 2006). In vitro characterization of an A-beta-42 specific heptapeptide selected by phage display and preliminary MRI evaluation of Alzheimer's disease detection by functionalized USPIO. Poster session presented at Annual Meeting of the European Society for Magnetic Resonance in Medicine and Biology, Varsovie, Poland. |
Larbanoix, L., Burtea, C., Laurent, S., Vansthertem, D., Toubeau, G., Van Leuven, F., Vander Elst, L., & Muller, R. (15 May 2006). Identifications par phage display et caractérisations in vitro d'heptapeptides ciblant le peptide amyloïde A-beta-42 qui permettront la détection par imagerie moléculaire des plaques séniles de la maladie d'Alzheimer. Poster session presented at Journées franco-belges de Pharmacochimie, Lille, France. |
 | Burtea, C., Laurent, S., Vander Elst, L., Toubeau, G., & Muller, R. (15 May 2006). Molecular imaging of angiogenic blood vessels in vulnerable atherosclerotic plaques with a mimetic of RGD peptide grafted to Gd-DTPA. Poster session presented at Opening Life Science Facilities, Philips Research Europe, Eindhoven, Netherlands. |
 | Parac-Vogt, T. N., Vander Elst, L., Kimpe, K., Laurent, S., Burtea, C., Chen, F., Vand Deun, R., Ni, Y. C., Muller, R., & Binnemans, K. (01 January 2006). Pharmacokinetic and in vivo evaluation of a self-assembled gadolinium(III)-iron(II) contrast agent with high relaxivity. Contrast Media and Molecular Imaging, 1 (6), 267-278. doi:10.1002/cmmi.114 Peer Reviewed verified by ORBi |
Laumonier, C., Segers, J., Burtea, C., Vander Elst, L., & Muller, R. (29 October 2005). Selecting vectors to image apoptosis by phage display technique. Paper presented at Contrast Media Research Symposium, San Diego, United States - California. |
 | Burtea, C., Larbanoix, L., Laurent, S., Toubeau, G., Vander Elst, L., & Muller, R. (01 October 2005). Phage display screening for peptides that specifically target the amyloid peptide A-beta1-42 for molecular imaging of the senile plaques in Alzheimer disease. Paper presented at Contrast Media Research Symposium, Evian, France. |
 | Larbanoix, L., Burtea, C., Laurent, S., Vander Elst, L., & Muller, R. (20 September 2005). Research of peptides with specific affinity for the amyloid peptide A-beta1-42 by phage display for the MRI detection of amyloid plaques in Alzheimer disease. Paper presented at Annual Meeting of the European Society of Magnetic Resonance in Medicine and Biology, Basel, Switzerland. |
 | Laurent, S., Burtea, C., Vander Elst, L., Yamamoto, T., Shimokawa, H., Katayama, Y., & Muller, R. (15 September 2005). Gd-EB-DTPA, a new dye-based MRI contrast agent. Paper presented at Annual Meeting of the European Society of Magnetic Resonance in Medicine and Biology, Basel, Switzerland. |
 | Burtea, C., Larbanoix, L., Laurent, S., Vander Elst, L., & Muller, R. (15 September 2005). Synthèse et caractérisation physico-chimique et biologique d'un agent de contraste vectorisé par un dérivé du stilbène destiné au diagnostic par IRM de la maladie d'Alzheimer. Poster session presented at Symposium on structure-based drug design (SRC), Mons, Belgium. |
 | Laurent, S., Burtea, C., Larbanoix, L., Toubeau, G., Van Leuven, F., Vander Elst, L., & Muller, R. (15 September 2005). Preliminary investigations on the synthesis, physicochemical and biological characterization of a new stilbene derivative grafted to USPIO dedicated to MRI diagnosis of Alzheimer disease. Paper presented at Annual Meeting of the European Society of Magnetic Resonance in Medicine and Biology, Basel, Switzerland. |
 | Yamashita, M., Aoshima, K., Kobayashi, M., Kato, T., Kamikage, N., Takahashi, M., Takayanagi, H., Oshikawa, T., Laurent, S., Burtea, C., Vander Elst, L., & Muller, R. (21 August 2005). Studies on novel MRI contrast agents for targeting organs and blood vessels. Paper presented at 13th European Carbohydrate symposium, Bratislava, Slovakia. |
Larbanoix, L., Burtea, C., Laurent, S., Murariu, O., Vansthertem, D., Toubeau, G., Van Leuven, F., Vander Elst, L., & Muller, R. (15 June 2005). In vitro characterization of A-beta-42 specific heptapeptides selected by phage display and preliminary studies on Alzheimer's disease diagnosis by MRI with peptide-functionalized contrast agents. Poster session presented at International Conference of the European Society of Molecular Imaging, Naples, Italy. |
 | Burtea, C., Laurent, S., Chaabane, L., Canet Soulas, E., Vander Elst, L., & Muller, R. (30 May 2005). Molecular targeting of angiogenic blood vessels in atherosclerotic plaques with a new low molecular weight non-peptidic RGD mimetic. Poster session presented at Proceedings of the International Society for Magnetic Resonance in Medicine, Miami, United States - Florida. |
 | Laurent, S., Burtea, C., Vander Elst, L., & Muller, R. (30 May 2005). Synthesis and characterisation of new low molecular weight lysine-conjugated Gd-DTPA contrast agents suited for MR angiography. Poster session presented at Proceedings of the International Society for Magnetic Resonance in Medicine, Miami, United States - Florida. |
 | Segers, J., Laumonier, C., Laurent, S., Burtea, C., Vander Elst, L., & Muller, R. (30 May 2005). Stealthy magnetophages, a new tool for molecular imaging. Poster session presented at Proceedings of the International Society for Magnetic Resonance in Medicine, Miami, United States - Florida. |
 | Burtea, C., Laurent, S., Vander Elst, L., & Muller, R. (15 May 2005). New perspectives in magnetic resonance molecular imaging. Poster session presented at Nanowal (Wallonia Network for Nanotechnologies), Mons, Belgium. |
 | Burtea, C., Laurent, S., Murariu, O., Larbanoix, L., Vander Elst, L., & Muller, R. (15 May 2005). A novel relaxometric method for the measurement of biochemical reactions based on functionalized magnetic nanoparticles. Poster session presented at Nanowal (Wallonia Network for Nanotechnologies), Mons, Belgium. |
 | Burtea, C., Laurent, S., Roch, A., Vander Elst, L., & Muller, R. (01 January 2005). C-MALISA (cellular magnetic-linked immunosorbent assay), a new application of cellular ELISA for MRI. Journal of Inorganic Biochemistry, 99 (5), 1135-1144. doi:10.1016/j.jinorgbio.2005.02.009 Peer Reviewed verified by ORBi |
 | Boutry, S., Burtea, C., Laurent, S., Toubeau, G., Vander Elst, L., & Muller, R. (01 January 2005). Magnetic resonance imaging of inflammation with a specific selectin-targeted contrast agent. Magnetic Resonance in Medicine, 53 (4), 800-807. doi:10.1002/mrm.20403 Peer Reviewed verified by ORBi |
 | Boutry, S., Burtea, C., Laurent, S., Toubeau, G., Vander Elst, L., & Muller, R. (2005). Magnetic Resonance Imaging of Inflammation With a Specific Selectin-Targeted Contrast Agent. Magnetic Resonance in Medicine. Peer Reviewed verified by ORBi |
 | Parac-Vogt, T. N., Kimpe, K., Laurent, S., Vander Elst, L., Burtea, C., Chen, F., Muller, R., Ni, Y. C., Verbruggen, A., & Binnemans, K. (01 January 2005). Synthesis, characterization, and pharmacokinetic evaluation of a potential MRI contrast agent containing two paramagnetic centers with albumin binding affinity. Chemistry, 11 (10), 3077-3086. doi:10.1002/chem.200401207 Peer Reviewed verified by ORBi |
 | Burtea, C., Laurent, S., Roch, A., Vander Elst, L., & Muller, R. (10 December 2004). Streptavidin-based magnetic nanosensors as an useful tool in clinical diagnosis. Poster session presented at Chemistry and self-assembly for nanotechnology, FUNDP, Namur, Belgium. |
 | Gossuin, Y., Burtea, C., Monseux, A., Toubeau, G., Roch, A., Muller, R., & Gillis, P. (11 May 2004). Ferritin-induced relaxation in tissues: An in vitro study. Journal of Magnetic Resonance Imaging, 20 (4), 690-697. doi:10.1002/jmri.20152 Peer Reviewed verified by ORBi |
Burtea, C., Laurent, S., Vander Elst, L., & Muller, R. (01 January 2004). C-MALISA (Cellular Magneted-Linked Immunosorbent Assay) as a new strategy in molecular MRI. Poster session presented at AMI annual meeting, Orlando, United States - Florida. |
 | Burtea, C., Laurent, S., Vander Elst, L., & Muller, R. (01 January 2004). Preclinical evaluation of several Integrin-targeted contrast agents. Poster session presented at 21th Annual Meeting of the European Society for Magnetic Resonance in Medicine and Biology, Copenhague, Denmark. |
Burtea, C., Laurent, S., Vander Elst, L., & Muller, R. (01 January 2004). Development of molecular contrast agents for MRI. Poster session presented at Cost B12, Radiotracers for in vivo assessment of biological function, 7th Cost B12 WG3 meeting, Radiolabeled biologically active peptides, Ljubljana, Slovenia. |
 | Burtea, C., Laurent, S., Roch, A., Vander Elst, L., & Muller, R. (01 January 2004). Highly sensitive Streptavidin-based magnetic nanosensors as an useful tool in clinical diagnosis. Poster session presented at 21th Annual Meeting of the European Society for Magnetic Resonance in Medicine and Biology, Copenhague, Denmark. |
Burtea, C., Chaabane, L., Laurent, S., Canet Soulas, E., Vander Elst, L., Briguet, A., & Muller, R. (01 January 2004). Preclinical evaluation of a new alpha(v)-beta(3)-targeted nonpeptidic RGD mimetic grafted to USPIO. Preliminary investigations on the molecular imaging of vulnerable atherosclerotic plaques. Poster session presented at 21th Annual Meeting of the European Society for Magnetic Resonance in Medicine and Biology, Copenhague, Denmark. |
Yamashita, M., Laurent, S., Burtea, C., Vander Elst, L., & Muller, R. (01 January 2004). A new glycosylated complex of gadolinium, a new potential contrast agent for MR angiography ? Poster session presented at ISMRM, Kyoto, Japan. |
Kimpe, K., Laurent, S., Vogt, T., Burtea, C., Henrotte, V., Vander Elst, L., Binnemans, K., & Muller, R. (01 January 2004). A novel efficient MRI contrast agent containing two paramagnetic centra. Poster session presented at ISMRM, Kyoto, Japan. |
Burtea, C., Laurent, S., Vander Elst, L., & Muller, R. (07 December 2003). Targeting of integrins with specific contrast agents for the in vitro and in vivo diagnostics of inflammatory pathologies by Magnetic Resonance Imaging. Poster session presented at Symposium on structure-based drug design, SRC, UCL, Louvain-la-Neuve, Unknown/unspecified. |
Laumonier, C., Segers, J., Burtea, C., Laurent, S., Michel, A., Vander Elst, L., & Muller, R. (07 December 2003). MR imaging of apoptosis using a phage display designed contrast agent. Poster session presented at Symposium on structure-based drug design, SRC, UCL, Louvain-la-Neuve, Unknown/unspecified. |
Burtea, C., Laurent, S., Vander Elst, L., & Muller, R. (07 December 2003). C-MLISA (Cellular Magnetic-Linked Immunosorbent Assay), une nouvelle apllication d'ELISA cellulaire pour l'imagerie de résonance magnétique. Poster session presented at SRC, Mons, Belgium. |
Laumonier, C., Segers, J., Laurent, S., Burtea, C., Michel, A., Vander Elst, L., & Muller, R. (07 December 2003). Ciblage de la phosphatidylsérine par phage display: synthèse d'un agent de contraste IRM spécifique de l'apoptose. Poster session presented at SRC, Mons, Belgium. |
Burtea, C., Laurent, S., Lecocq, S., Vander Elst, L., Colet, J.-M., & Muller, R. (06 December 2003). Importance des sucres à chaine ouverte sur la prolongation du temps de demi-vie des dérivés du Gd-DTPA. Poster session presented at 10ème Congrès du GRAMM, Angers, France. |
 | Burtea, C., Laurent, S., Vander Elst, L., & Muller, R. (06 December 2003). C-MLISA (Cellular Magnetic-Linked Immunosorbent Assay), a new application of cellular ELISA for MRI. Poster session presented at 20th Annual Meeting of the European Society for Magnetic Resonance in Medicine and Biology, Rotterdam, Netherlands. |
 | Laumonier, C., Segers, J., Burtea, C., Laurent, S., Vander Elst, L., & Muller, R. (06 December 2003). Targeting phosphatidylserine by phage display to image apoptosis. Poster session presented at New in vivo imaging modalities for molecular biology, cell biology and physiology, Conférences Jacques-Monod, Roscoff, France. |
Laumonier, C., Segers, J., Burtea, C., Laurent, S., Vander Elst, L., & Muller, R. (01 January 2003). Targeting phosphatidylserine by phage display to image apoptosis. Poster session presented at XVIIe journées franco-belges de pharmacochimie : de la conception à la réalisation en pharmacochimie, UCL, Bruxelles, Belgium. |
Boutry, S., Burtea, C., Laurent, S., Vander Elst, L., & Muller, R. (01 January 2003). Targeting inflammation in MRI with a superparamagnetic contrast agent. Poster session presented at XVIIe journées franco-belges de pharmacochimie : de la conception à la réalisation en pharmacochimie, UCL, Bruxelles, Belgium. |
 | Burtea, C., Laurent, S., Colet, J.-M., Vander Elst, L., & Muller, R. (01 January 2003). Development of new glucosylated derivatives of Gd-DTPA for MRI angiography. Investigative Radiology, 38 ((6)), 320-333. doi:10.1097/01.RLI.0000066251.65982.e6 Peer Reviewed verified by ORBi |
 | Boutry, S., Burtea, C., Laurent, S., Vander Elst, L., & Muller, R. (01 January 2003). Targeting inflammation in MRI with a superparamagnetic contrast agent. Poster session presented at New in vivo imaging modalities for molecular biology, cell biology and physiology, Conférences Jacques-Monod, Roscoff, France. |
Burtea, C., Boutry, S., Laurent, S., & Muller, R. (06 December 2002). E-selectin targeting, a new strategy for inflammation imaging. Paper presented at 'New Developments in Contrast Agent Research', 8th Bi-annual Conference on MR and Intermodality Contrast Agent Research, Budapest, Hungary. |
Laumonier, C., Segers, J., Burtea, C., & Muller, R. (22 August 2002). Identification of a peptidic high affinity for phosphatidylserine to target apoptosis by MRI. Paper presented at 19th Annual Scientific Meeting of the European Society of Magnetic Resonance in Medicine and Biology, Cannes, France. |
Burtea, C., Laurent, S., & Muller, R. (22 August 2002). A VLA-4 targeted contrast agent for the MRI labeling of mononuclear cells in inflammatory pathologies. Paper presented at 19th Annual Scientific Meeting of the European Society of Magnetic Resonance in Medicine and Biology, Cannes, France. |
 | Boutry, S., Burtea, C., Laurent, S., & Muller, R. (22 August 2002). Development of a superparamagnetic contrast agent specific for inflammation. Paper presented at 19th Annual Scientific Meeting of the European Society of Magnetic Resonance in Medicine and Biology, Cannes, France. |
Burtea, C., Laurent, S., Lecocq, S., Vander Elst, L., & Muller, R. (22 August 2002). Synthesis and evaluation of some new glycosylated derivatives of Gd-DTPA as MRI blood pool contrast agents. Paper presented at 19th Annual Scientific Meeting of the European Society of Magnetic Resonance in Medicine and Biology, Cannes, France. |
 | Muller, R., Vander Elst, L., Laurent, S., Colet, J.-M., Fu, Y., Segers, J., Burtea, C., Boutry, S., & Laumonier, C. (04 December 2001). New trends in the development of MRI contrast media. Paper presented at 10 th International Conference on Bioinorganic Chemistry, ICBIC 10, Florence, Italy. |
Vander Elst, L., Laurent, S., Burtea, C., Fu, Y., & Muller, R. (04 December 2001). Sugar derivatives of lanthanide complexes, MRI contrast agents of increased specificity. Paper presented at Contrast Media Research (CMR 2001), Capri, Italy. |
Burtea, C., Laurent, S., Vander Elst, L., Roch, A., Sinnaeve, G., Baeten, V., & Muller, R. (04 December 2000). 1H and 13C NMR investigations on cocoa butter authenticity. Paper presented at 1H and 13C NMR investigations on cocoa butter authenticity, Lednice, Czechia. |
Dumitru, I., Burtea, C., Balta, N., Stoian, G., Mekhalfia, A., & Petec, G. (19 November 1998). An assay on blood, heart and liver biochemical markers in myocardial hypertrophy induced by isoproterenol. Romanian Biotechnological Letters, 3 (3), 221-236. Peer Reviewed verified by ORBi |
 | Burtea, C., Gatina, R., Stoian, G., Mardare, M., Dumitru, I., & Dragomir, C. (03 November 1998). Spin-spin relaxation times in myocardial hypertrophy induced by endocrine agents in rat. Magnetic Resonance Materials in Biology, Physics and Medicine, 7, 184-198. doi:10.1007/BF02591336 Peer Reviewed verified by ORBi |
Burtea, C., Stoian, G., Mekhalfia, A., Balta, N., & Dumitru, I. (15 October 1998). Metabolic alterations in rat myocardium and liver after treatment with high doses of ACTH and isoproterenol. Journal of Medicine and Biochemistry, 3 (1), 35-51. Peer reviewed |
Burtea, C., Gatina, R., Mardare, M., Stoian, G., Dumitru, I., & Dragomir, C. (17 September 1998). 1H-NMR investigations on water permeability of rat erythrocytes in endocrine induced myocardial hypertrophy. Paper presented at 15th Scientific Meeting of the European Society for Magnetic Resonance in Medicine and Biology, Geneva, Switzerland. |
Burtea, C., Mardare, M., Stoian, G., Mihalache, D., Dumitru, I., & Dragomir, C. (23 August 1998). The T2 evolution in myocardial tissue depending on pH, KCl concentration and alteration of contractile protein thiol in physiological and pathological conditions. Paper presented at 15th Scientific Meeting of the European Society for Magnetic Resonance in Medicine and Biology, Geneva, Switzerland. |
Gatina, R., Balta, N., Moisin, C., Burtea, C., Botea, S., Ioan, M., & Teleianu, C. (10 July 1998). Research on red cell membrane permeability in arterial hypertension. Romanian Journal of Physiology: Physiological Sciences, 35 (3-4), 285-302. Peer Reviewed verified by ORBi |
Dumitru, I., Burtea, C., Stoian, G., Mardare, M., Mekhalfia, A., & Balta, N. (15 June 1998). Tissue water alterations in rat liver and myocardium exposed to ACTH and isoproterenol treatment. A relaxometric study. Journal of Medicine and Biochemistry, 2 (3), 237-249. Peer reviewed |
Miscalencu, D., Dumitru, I., Mailat, F., Burtea, C., Ivanciuc, L., & Barbu, E. (11 June 1998). Ultrastructural changes induced by isoproterenol and ACTH in hepatocytes and heart myocytes. Journal of Medicine and Biochemistry, 2 (4), 353-359. Peer reviewed |
Dumitru, I., Burtea, C., Stoian, G., Mardare, M., Mekhalfia, A., & Balta, N. (1998). Modulation of the enzymes involved in rat liver glutathione metabolism by high doses of ACTH and isoproterenol. Journal of Medicine and Biochemistry. Peer reviewed |
Dumitru, I., Balta, N., Burtea, C., Stoian, G., Mekhalfia, A., & Petec, G. (19 November 1997). Cardioprotective effect of fosfobion and thiamin in isoproterenol-induced myocardial hypertrophy. Journal of Medicine and Biochemistry, 1 (4), 273-290. |
Balta, N., Stoian, G., Boca, A., Burtea, C., Petec, G., Moisin, C., Teleianu, C., & Dumitru, I. (17 November 1997). Biochemical and histo-enzymological investigations of the myocardium and coronary system in assessing experimental cardiac hypertrophy. Journal of Medicine and Biochemistry, 1 (3), 161-182. Peer reviewed |
Mihalache, D., Burtea, C., Ungureanu, B., & Mateescu, C. (18 September 1997). Cellular water alterations in rat liver exposed to oncogenic stress. A relaxometric study. Paper presented at 14th Scientific Meeting of the European Society for Magnetic Resonance in Medicine and Biology, Brussels, Belgium. |
Burtea, C., Mateescu, C., Mardare, M., Stoian, G., Botea, S., & Mihalache, D. (18 September 1997). 1H-NMR in detection of the specific tissue injuries induced by hormones with cardiopathic potential. Paper presented at 14th Scientific Meeting of the European Society for Magnetic Resonance in Medicine and Biology, Brussels, Belgium. |
Burtea, C., & Mateescu, C. (18 September 1997). The usefulness of 1H and 23Na NMR spectrometry in the study of muscle contraction and of myopathic alteration. An approach of the influence of proteins and ions on T2 in muscle tissue. Paper presented at 14th Scientific Meeting of the European Society for Magnetic Resonance in Medicine and Biology, Brussels, Belgium. |
Burtea, C., Mihalache, D., & Ungureanu, B. (20 May 1997). Precocious signals detected by 1H-NMR in rat liver exposed to oncogenic stress, interfering with fat-soluble vitamins D3 and E. Libri Oncologici: Croatian Journal of Oncology, 26 (1), 19-24. Peer reviewed |
Burtea, C., Balta, N., Stoian, G., Petec, G., & Dumitru, I. (12 April 1997). A 1H-NMR study on the modulator effect of retinoic acid in the alcoholic intoxication. The identification of tissue water injuries induced by ethanol on liver and myocardium. Journal of Medicine and Biochemistry, 1 (1), 25-36. Peer reviewed |
Mocanu, M., Burtea, C., Gatina, R., & Botea, S. (18 September 1996). 1H-NMR measurements as a useful tool for detection of moderate changes on the myofilaments due to a subletal oxidative stress. Paper presented at 13th Scientific Meeting of the European Society for Magnetic Resonance in Medicine and Biology, Prague, Unknown/unspecified. |
Dumitru, I., Balta, N., Burtea, C., Stoian, G., & Petec, G. (16 May 1996). The protective role of thiamine associated with medicinal products based on biogenic amines and the metabolic modifications made evident by 1H-NMR. Romanian Biotechnological Letters, 1 (3), 171-180. Peer Reviewed verified by ORBi |
Burtea, C., Mocanu, M., Mardare, M., Gatina, R., & Botea, S. (01 May 1996). 1H-NMR technique in detection of testosterone involvement in the risk of myocardial infarction and the role of tocopherol in protection. Paper presented at 13th Scientific Meeting of the European Society for Magnetic Resonance in Medicine and Biology, Prague, Unknown/unspecified. |
Burtea, C., Gatina, R., Dinischiotu, A., Mocanu, M., & Nastasescu, G. (17 November 1995). Studies on the steroid hormones involvement in the muscular fatigue phenomena. Studii si Cercetari de Biochimie, 38 (1-2), 11-18. Peer reviewed |
Burtea, C., Gatina, R., Vasilescu, A., & Nastasescu, G. (11 November 1995). NMR and radioizotope studies concerning the steroid hormones influence over the contractile proteins of skeletal muscle. Studii si Cercetari de Biochimie, 38 (1-2), 3-10. Peer reviewed |
Burtea, C., Gatina, R., Mocanu, M., Dinischiotu, A., & Nastasescu, G. (07 April 1995). Catecholamines and Ca2+ involvement in potentiating the resistance to physical effort induced by anabolic steroids. Sex-related differences. Romanian Journal of Endocrinology, 33 (1-4), 31-39. Peer Reviewed verified by ORBi |
Botea, S., Burtea, C., & Mocanu, M. (07 April 1995). The influence of oestradiol treatment upon the protection conferred by preconditioning in ischaemic rat myocardium in vitro. Romanian Journal of Endocrinology, 33 (3-4), 49-55. Peer Reviewed verified by ORBi |
Burtea, C., Gatina, R., Lefter, C., David, A., Nastasescu, G., & Butnaru, F. (15 October 1993). The role of cathecolamines in muscle growth. Romanian Journal of Endocrinology, 31 (3-4), 115-122. Peer Reviewed verified by ORBi |
Burtea, C., David, A., & Butnaru, F. (10 April 1993). The role of catecholamines in the distribution of steroid hormones in the striated and cardiac muscle. Romanian Journal of Endocrinology, 31 (1-2), 41-48. Peer Reviewed verified by ORBi |
Burtea, C., Lefter, C., Butnaru, F., & David, A. (20 October 1992). Steroid hormones control on nucleic acid biosynthesis in skeletal muscle. Romanian Journal of Endocrinology, 30 (3-4), 109-114. Peer Reviewed verified by ORBi |
Burtea, C., Murgiuc, C., David, A., & Dragomir, C. (25 September 1992). Influence of sex and glucocorticoid hormones on 3H-cholesterol uptake in the aortic wall and 3H-adrenaline in the brain. Romanian Journal of Endocrinology, 29 (3-4), 137-145. Peer Reviewed verified by ORBi |
